Norman C. Madsen, BMBS

Norman Madsen practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Norman Madsen's NPI, 1053923441, was assigned on August 18, 2020. Norman Madsen graduated from The Flinders University of South Australia School of Medicine in 2010. Norman Madsen holds New York license 305959.

Norman Madsen's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Norman Madsen's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Norman Madsen is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Norman Madsen to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Norman Madsen practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Norman Madsen's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Norman Madsen is licensed in New York.

CMS data shows 298 Medicare services from Norman Madsen across 3 procedure codes in 2024, for 127 Medicare patients. Medicare paid $11,128 for them. Every service was in an office.

CMS counts 127 Medicare patients who saw Norman Madsen in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have arthritis, and 68% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Norman Madsen's median patient age at 61, with 65% women.

In 2024, Norman Madsen wrote 1,773 Medicare Part D claims for 256 patients. 58% of them were for generic drugs. CMS names the drug for 1,624 of them, across 36 drugs with 11 or more claims each, at $4,991,207 in total drug cost. In 2023, CMS named 1,472 claims across 33 drugs.

Norman Madsen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Norman Madsen as offering telehealth.

Dmand AI links 1 paper to Norman Madsen in 2023. Norman Madsen's most frequent co-authors are Brianna Caraet, MD, Thomas John Carroll, MD and Danielle Marie Wilbur, MD.

CMS Open Payments shows 7 general payments to Norman Madsen from 3 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 96% of the total. Eli Lilly and Company paid the most, $6,310.

Norman Madsen graduated from The Flinders University of South Australia School of Medicine in 2010.